Kategórie: Novinky
Novinky
Spoločnosť SOM Biotech ukončila nábor do štúdie fázy IIb liečby chorey pri Huntingtonovej chorobe
SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary Artificial Intelligence platform (SOMAIPRO®), is pleased to announce that the recruitment of the Phase IIb clinical study with SOM3355 as a Prečítajte si viac...
0 Komentáre